NASDAQ | ETF
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies.
A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health.
The fund is non-diversified.
Top 17 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 6.22% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.73% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.63% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.79% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 4.40% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.10% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.06% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.02% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.82% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 3.70% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.53% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 3.53% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 3.52% |
| UCB | UCB SA | Healthcare | Biotechnology | 3.47% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 3.35% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 3.21% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.12% |